Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hows, J. M.
Right arrow Articles by Goldman, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hows, J. M.
Right arrow Articles by Goldman, J. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia

JM Hows, JL Yin, J Marsh, D Swirsky, L Jones, JF Apperley, DC James, S Smithers, JR Batchelor and JM Goldman

We treated 14 patients by transplantation of marrow from unrelated volunteer donors. Eight patients had severe aplastic anemia, 3 had chronic granulocytic leukemia, and 3 had Fanconi's anemia. The results are compared with those of a group of 14 similar patients transplanted concurrently from human leukocyte antigen (HLA)-mismatched family members: Sustained engraftment was achieved in 8 of 14 patients in both groups; one additional patient survived with autologous marrow reconstitution following an unrelated donor transplant. In the unrelated donor group, 6 of 9 evaluable patients developed grade III through IV acute graft-v-host disease, as compared with 4 of 9 patients after family-mismatched transplants. Overall survival was similar in the two groups. In the unrelated donor group 4 of 14 (29%) patients survived (median survival 1,299 days) as compared with 5 of 14 (36%) in the mismatched-family donor group (median survival 808 days). In both groups, patients with HLA phenotypically matched donors fared better than those with donors who were mismatched for one or more HLA antigen. Of the patients transplanted from HLA phenotypically matched donors 6 of 12 patients (50%) survived, as compared with 3 of 16 patients (19%) transplanted from HLA-mismatched donors. We conclude that unrelated donor bone marrow transplantation (BMT) should be considered in those cases of leukemia or bone marrow failure in which the chance of cure using conventional therapy is remote and a HLA genotypically or phenotypically matched family donor is not available.

Volume 68, Issue 6, pp. 1322-1328, 12/01/1986
Copyright © 1986 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
H. J. Deeg, M. O'Donnell, J. Tolar, R. Agarwal, R. E. Harris, S. A. Feig, M. C. Territo, R. H. Collins, P. A. McSweeney, E. A. Copelan, et al.
Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy
Blood, September 1, 2006; 108(5): 1485 - 1491.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. J. Jordan, P. A. Brookes, R. M. Szydlo, J. M. Goldman, R. I. Lechler, and M. A. Ritter
IL-13 production by donor T cells is prognostic of acute graft-versus-host disease following unrelated donor stem cell transplantation
Blood, January 15, 2004; 103(2): 717 - 724.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Bunin, M. Carston, D. Wall, R. Adams, J. Casper, N. Kamani, R. King, and the National Marrow Donor Program Working Group
Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission
Blood, May 1, 2002; 99(9): 3151 - 3157.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. Sasazuki, T. Juji, Y. Morishima, N. Kinukawa, H. Kashiwabara, H. Inoko, T. Yoshida, A. Kimura, T. Akaza, N. Kamikawaji, et al.
Effect of Matching of Class I HLA Alleles on Clinical Outcome after Transplantation of Hematopoietic Stem Cells from an Unrelated Donor
N. Engl. J. Med., October 22, 1998; 339(17): 1177 - 1185.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. J. Henslee-Downey, S. H. Abhyankar, R. S. Parrish, A. R. Pati, K. T. Godder, W. J. Neglia, K. S. Goon-Johnson, S. S. Geier, C. G. Lee, and A. P. Gee
Use of Partially Mismatched Related Donors Extends Access to Allogeneic Marrow Transplant
Blood, May 15, 1997; 89(10): 3864 - 3872.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. W. Petersdorf, G. M. Longton, C. Anasetti, E. M. Mickelson, A. G. Smith, P. J. Martin, and J. A. Hansen
Definition of HLA-DQ as a transplantation antigen
PNAS, December 24, 1996; 93(26): 15358 - 15363.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
N. A. Kernan, G. Bartsch, R. C. Ash, P. G. Beatty, R. Champlin, A. Filipovich, J. Gajewski, J. A. Hansen, J. Henslee-Downey, J. McCullough, et al.
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
N. Engl. J. Med., March 4, 1993; 328(9): 593 - 602.
[Abstract] [Full Text]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1986 by American Society of Hematology         Online ISSN: 1528-0020